Do CVID patients on SCIG have more autoimmune (thrombo)cytopenic events than CVID patients on IVIG?

Autoimmune thrombocytopenia (AITP) is frequent in patients diagnosed with common variable immunodeficiency (CVID). High dose intravenous immunoglobulin treatment (IVIG) has conventionally been a cornerstone of the initial therapy for AITP. This study aimed to assess the safety and effectiveness of s...

Full description

Bibliographic Details

Main Authors:	Nadezhda Camacho-Ordonez, Aleksandra Hirsch, Luiza Campos, Sigune Goldacker, Siobhan O. Burns, Fernando Moreira, Klaus Warnatz, Bodo Grimbacher
Format:	Artigo
Language:	Inglês
Published:	Frontiers Media S.A. 2025-11-01
Series:	Frontiers in Immunology
Subjects:	autoimmune thrombocytopenia intravenous or subcutaneous immunoglobulin common variable immunodeficiency autoimmunity cytopenia
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1708813/full
Tags:	Add Tag No Tags, Be the first to tag this record!